TAS::75 0849::TAS R&D-OTHER SCIENCES-B RES

塔斯马尼亚::75 0849::塔斯马尼亚 R

• 批准号: 8164676
• 负责人: ALLEN Y. TIEN
• 金额: $ 100万
• 依托单位: MEDICAL DECISION LOGIC, INC.
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-24 至 2013-03-23
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8164676
• 关键词: TAS; 75; 0849; R&D; OTHER

The goal of this project is to develop a commercially and scientifically successful software system, named Teli Us Medicine, designed to meet current and future needs in palliative and hospice care markets, addressing the management of pain and other symptoms to improve quality of life. A core purpose for Tell Us Medicine is data-based communication with, and between, patients and their families, professional care providers, administrators, and researchers. Based on HL7, CDISC, and caBIG models and standards, and an existing health science-architected web technology platform , the data infrastructure for Tell Us Medicine will enable integration, interoperability, and ongoing adaptability to evolving scientific knowledge, best practices, and innovation. The system is purely web-based, so that the software can be accessed and used with any web-enabled devices, including devices such as smartphones and tablets. The focus in Phase II is standard personal computers in home and office settings.

该项目的目标是开发一个商业和科学上成功的软件系统， Teli Us Medicine旨在满足姑息治疗和临终关怀市场的当前和未来需求， 解决疼痛和其他症状的管理，以提高生活质量。Tell的核心目的 US Medicine是基于数据的沟通，患者及其家属，专业护理 供应商、管理人员和研究人员。基于HL7、CDISC和caBIG模型和标准， 一个现有的健康科学架构的网络技术平台，告诉我们医学的数据基础设施 将使集成，互操作性和不断适应不断发展的科学知识，最好的 实践和创新。该系统完全基于网络，因此可以访问和使用该软件 任何支持Web的设备，包括智能手机和平板电脑等设备。第二阶段的重点是 家庭和办公室环境中的标准个人计算机。